Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.50 |
| ▸ | BCHE | P06276 | 4/20 | 0.48 |
| ▸ | KDM1A | O60341 | 3/20 | 0.47 |
| ▸ | PIM1 | P11309 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10023985 | 0.82 | MEN1 (0.58) | MEN1KMT2ALMNAPTGS1PTGS2 | |
| SCHEMBL48681 | 0.80 | MEN1 (0.58) | MEN1KMT2ALMNAKDM1APIM1 | |
| SCHEMBL30115198 | 0.80 | MEN1 (0.58) | MEN1KMT2ALMNAKDM1APIM1 | |
| SCHEMBL30115197 | 0.80 | MEN1 (0.58) | MEN1KMT2ALMNAKDM1APIM1 | |
| SCHEMBL49291 | 0.78 | PIM1 (0.59) | MEN1KMT2ALMNAKDM1APIM1 | |
| SCHEMBL8444747 | 0.78 | MEN1 (0.57) | MEN1KMT2ALMNAKDM1APIM1 | |
| SCHEMBL48847 | 0.78 | MEN1 (0.57) | MEN1KMT2ALMNAKDM1APIM1 | |
| SCHEMBL31384188 | 0.78 | PIM1 (0.59) | MEN1KMT2ALMNAKDM1APIM1 | |
| SCHEMBL3774114 | 0.77 | PIM1 (0.58) | MEN1KMT2ALMNAKDM1APIM1 | |
| Promazine SCHEMBL27679140 | 0.73 | CYP2D6 (0.78) | MEN1KMT2ALMNAKDM1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7855287-B2 | Preparation of high purity phenothiazine N-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase activity | CYANAGEN SRL (IT) | 2010-12-21 | — | — | US | disclosed |
| US-7525716-B2 | Display device and display apparatus | RICOH COMPANY, LTD. (JP) | 2009-04-28 | — | — | US | disclosed |
| US-7489432-B2 | Electrochromic display device and display apparatus | RICOH COMPANY, LTD. (JP) | 2009-02-10 | — | — | US | disclosed |
| US-20080176251-A1 | Preparation of high purity phenothiazine N-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase acitivity | CYANAGEN SRL (IT) | 2008-07-24 | — | — | US | disclosed |
| US-20060215250-A1 | Electrochromic display device and display apparatus | RICOH COMPANY, LTD. (JP) | 2006-09-28 | — | — | US | disclosed |
| US-20060204866-A1 | Display device and display apparatus | RICOH COMPANY, LTD. (JP) | 2006-09-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176251-A1 | Preparation of high purity phenothiazine N-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase acitivity | LPO, ARSA, SULT1E1 | MEN1 3072/4885KMT2A 3382/4885LMNA 2980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.